Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipramine for PDT-induced Microvesicles
NCT03960125Phase 1Withdrawn
- Sponsor
- Wright State University
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of imipramine (2 arms), sponsored by Wright State University. Primary endpoints: Change in Microvesicle Particle Levels From Baseline with Photodynamic Therapy at Day 0 and Change in Microvesicle Particle Levels From Baseline with 4% Imipramine Cream Treatment at Day 2. Planned start Mar 2021; status: withdrawn.
02
Drugs
imipramine
Beyond the preview
Go deeper on NCT03960125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960125.